In 433 non-demented amyotrophic lateral sclerosis (ALS) patients, clinically significant anxiety was present in 18.2% for state anxiety and 13.9% for trait anxiety. The strongest predictor was not motor severity, cognition, or caregiver-rated behavior; it was depression, especially cognitive-affective depression symptoms.1 Research Highlights ALS anxiety was measurable but not universal: Aiello et al. found clinically …
The link between psychological stress and chronic inflammation is well-documented — what’s been less clear is which specific inflammatory proteins move with anxiety in real-world community samples. A 2026 analysis from Loomans-Kropp et al. measured a 33-marker panel in 190 minoritized and medically underserved adults from the Cancer Disparities Research Network and identified three biomarkers …
An 11-person case series tested delayed-release apple cider vinegar capsules in young adults who had gained weight while taking psychotropic medications, and metabolic markers carried more signal than weight loss. Research Highlights Feasibility was the strongest result: 11 of 12 enrolled participants completed the study, 10 of 11 completers missed 5 or fewer doses, and …
Whole-body hyperthermia looks less like generic relaxation and more like a timed biological stressor: in a small depression substudy, a single session was followed by early Hamilton Depression Rating Scale improvement, heat-shock gene activation, and immune-process enrichment that included interleukin 6 production. Research Highlights Depression scores improved early: in the 18-person RNA sequencing substudy, whole-body …
A 2026 BRFSS analysis involving 4,071 U.S. adults who used cannabis and either smoked cigarettes, vaped nicotine, or did both found a strong modality match: people who vaped tobacco were much more likely to vape cannabis than to smoke cannabis.1 For addiction and harm-reduction assessment, the pattern is a route-specific risk signal because smoking, vaping, …
A 2026 emergency department claims analysis estimated 3.87 million United States ED visits in 2021 where take-home naloxone could have been clinically relevant, compared with 226,453 ED-treated opioid-overdose visits in the same database.1 The finding reframes naloxone distribution as an emergency-care workflow for overdose risk, polysubstance exposure, long-term opioid use, and patients who arrive after …
A 2026 ABCD Study preprint found that teen substance-use initiation prediction improved more when models included changing risk over time than when they simply switched from logistic regression to multi-task learning.1 Dynamic models raised AUROC by 0.044 to 0.062 in multi-task learning and by 0.050 to 0.084 in logistic regression, which makes timing the main …